1. Cucolo, Lisa, Chen, Qingzhou, Qiu, Jingya, Shi, Junwei, Minn, Andy J. . The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade. In Immunity, 55, 671-685.e10. doi:10.1016/j.immuni.2022.03.007. https://pubmed.ncbi.nlm.nih.gov/35417675/
2. Degterev, Alexei, Ofengeim, Dimitry, Yuan, Junying. 2019. Targeting RIPK1 for the treatment of human diseases. In Proceedings of the National Academy of Sciences of the United States of America, 116, 9714-9722. doi:10.1073/pnas.1901179116. https://pubmed.ncbi.nlm.nih.gov/31048504/
3. Zelic, Matija, Pontarelli, Fabrizio, Woodworth, Lisa, Hammond, Timothy, Ofengeim, Dimitry. . RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis. In Cell reports, 35, 109112. doi:10.1016/j.celrep.2021.109112. https://pubmed.ncbi.nlm.nih.gov/33979622/
4. Newton, Kim. 2015. RIPK1 and RIPK3: critical regulators of inflammation and cell death. In Trends in cell biology, 25, 347-53. doi:10.1016/j.tcb.2015.01.001. https://pubmed.ncbi.nlm.nih.gov/25662614/
5. Karunakaran, Denuja, Turner, Adam W, Duchez, Anne-Claire, McPherson, Ruth, Rayner, Katey J. 2020. RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice. In Nature metabolism, 2, 1113-1125. doi:10.1038/s42255-020-00279-2. https://pubmed.ncbi.nlm.nih.gov/32989316/
6. Lalaoui, Najoua, Boyden, Steven E, Oda, Hirotsugu, Kastner, Daniel L, Silke, John. 2019. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. In Nature, 577, 103-108. doi:10.1038/s41586-019-1828-5. https://pubmed.ncbi.nlm.nih.gov/31827281/
7. Xu, Chong, Wu, Jialin, Wu, Yiqun, Chen, Xijing, Sima, Jian. 2021. TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG. In Theranostics, 11, 9452-9469. doi:10.7150/thno.62376. https://pubmed.ncbi.nlm.nih.gov/34646380/
智鼠故事 
